97 related articles for article (PubMed ID: 1697100)
1. Identity of HML-1 antigen on intestinal intraepithelial T cells and of B-ly7 antigen on hairy cell leukaemia.
Moldenhauer G; Mielke B; Dörken B; Schwartz-Albiez R; Möller P
Scand J Immunol; 1990 Aug; 32(2):77-82. PubMed ID: 1697100
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody HML-1, a marker for intraepithelial T cells and lymphomas derived thereof, also recognizes hairy cell leukemia and some B-cell lymphomas.
Möller P; Mielke B; Moldenhauer G
Am J Pathol; 1990 Mar; 136(3):509-12. PubMed ID: 2316623
[TBL] [Abstract][Full Text] [Related]
3. LF61: a new monoclonal antibody directed against a trimeric molecule (150 kDa, 125 kDa, 105 kDa) associated with hairy cell leukaemia.
Flenghi L; Spinozzi F; Stein H; Krushwitz M; Pileri S; Falini B
Br J Haematol; 1990 Dec; 76(4):451-9. PubMed ID: 2265107
[TBL] [Abstract][Full Text] [Related]
4. Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients.
Falini B; Pileri SA; Flenghi L; Liberati M; Stein H; Gerli R; Minelli O; Martelli MF; Lauria F; Poggi S
Br J Haematol; 1990 Dec; 76(4):460-8. PubMed ID: 1702309
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of monoclonal antibody B-ly7 with a subset of activated T cells and T-cell lymphomas.
Visser L; Dabbagh L; Poppema S
Hematol Pathol; 1992; 6(1):37-42. PubMed ID: 1601821
[TBL] [Abstract][Full Text] [Related]
6. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells.
Mulligan SP; Travade P; Matutes E; Dearden C; Visser L; Poppema S; Catovsky D
Blood; 1990 Sep; 76(5):959-64. PubMed ID: 2118401
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemia.
Thaler J; Dietze O; Faber V; Greil R; Gastl G; Denz H; Ho AD; Huber H
Leukemia; 1990 Mar; 4(3):170-6. PubMed ID: 2314116
[TBL] [Abstract][Full Text] [Related]
8. HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit.
Micklem KJ; Dong Y; Willis A; Pulford KA; Visser L; Dürkop H; Poppema S; Stein H; Mason DY
Am J Pathol; 1991 Dec; 139(6):1297-301. PubMed ID: 1750505
[TBL] [Abstract][Full Text] [Related]
9. Individual epitopes of an 85,000 MW membrane adherence molecule are variably expressed on cells of different lineage.
Schulz TF; Vogetseder W; Mitterer M; Böck G; Johnson JP; Dierich MP
Immunology; 1988 Aug; 64(4):581-6. PubMed ID: 2459048
[TBL] [Abstract][Full Text] [Related]
10. RAB-1: a new monoclonal antibody to leukemic hairy cells.
Berrebi A; Eshhar Z; Linder S; Guedj L; Avraham H
Leuk Res; 1986; 10(9):1071-8. PubMed ID: 3531732
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies reactive with hairy cell leukemia.
Visser L; Shaw A; Slupsky J; Vos H; Poppema S
Blood; 1989 Jul; 74(1):320-5. PubMed ID: 2665837
[TBL] [Abstract][Full Text] [Related]
12. Specificity of monoclonal antibody HML-1.
Pallesen G; Hamilton-Dutoit SJ
Lancet; 1990 Mar; 335(8688):537. PubMed ID: 1968544
[No Abstract] [Full Text] [Related]
13. Specificities of monoclonal antibodies B-ly7 and HML-1 are identical.
Schwarting R; Dienemann D; Kruschwitz M; Fritsche G; Stein H
Blood; 1990 Jan; 75(1):320-1. PubMed ID: 2294994
[No Abstract] [Full Text] [Related]
14. Immunogold labelling of leukemic hairy cells with the B-ly7 monoclonal antibody: an SEM and TEM study.
de Harven E; Christensen H; Poppema S; Scott JG
Microsc Res Tech; 1994 Jul; 28(4):356-67. PubMed ID: 7919522
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody HML-1 reactivity with adult T-cell leukaemia/lymphoma and other lymphomas.
Kitajima S; Tokunaga M; Goto M; Sato E; Utsunomiya A; Ohtsuka M; Hanada S; Arima T
Histopathology; 1994 Sep; 25(3):229-36. PubMed ID: 7821890
[TBL] [Abstract][Full Text] [Related]
16. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.
Korsmeyer SJ; Greene WC; Cossman J; Hsu SM; Jensen JP; Neckers LM; Marshall SL; Bakhshi A; Depper JM; Leonard WJ; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4522-6. PubMed ID: 6192435
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of surface immunoglobulin and T3 on hairy cells.
Haegert DG; Furlong MD; Smith JL
Scand J Haematol; 1986 Sep; 37(3):196-202. PubMed ID: 3097806
[TBL] [Abstract][Full Text] [Related]
19. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
20. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
Norton AJ; Isaacson PG
Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
